Cargando…

Use of Thiols in the Treatment of COVID-19: Current Evidence

There is a possible role for oxidative stress, a state characterized by an altered balance between the production of free radicals or reactive oxygen species (ROS) and antioxidant defences, in coronavirus disease 2019 (COVID-19), the genesis of which is quite complex. Excessive oxidative stress coul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cazzola, Mario, Rogliani, Paola, Salvi, Sundeep Santosh, Ora, Josuel, Matera, Maria Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review: Use of Thiols in Treatment of Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390541/ https://www.ncbi.nlm.nih.gov/pubmed/34448938 http://dx.doi.org/10.1007/s00408-021-00465-3

Ejemplares similares

Guidance on nebulization during the current COVID-19 pandemic
por: Cazzola, Mario, et al.
Publicado: (2021)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017)

Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2019)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2021)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
por: Cazzola, Mario, et al.
Publicado: (2023)

LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment
por: Calzetta, Luigino, et al.
Publicado: (2017)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells
por: Cazzola, Mario, et al.
Publicado: (2016)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

Pharmacological treatment and current controversies in COPD
por: Cazzola, Mario, et al.
Publicado: (2019)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020)

Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
por: Rogliani, Paola, et al.
Publicado: (2022)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils
por: Rogliani, Paola, et al.
Publicado: (2016)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
por: Manzetti, Gian Marco, et al.
Publicado: (2023)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
por: Matera, Maria Gabriella, et al.
Publicado: (2020)

A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
por: Hossen, Md. Shafiul, et al.
Publicado: (2020)

Understanding opioid use within a Southwestern American Indian Reservation Community: A qualitative study
por: Waugh, Emma, et al.
Publicado: (2022)

Results of COVID-19 screening in a dermatologic clinic in Northern Italy
por: BURLANDO, MARTINA, et al.
Publicado: (2023)

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
por: Calzetta, Luigino, et al.
Publicado: (2019)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy
por: Parodi, Italo Carlo, et al.
Publicado: (2020)

Current and Future Challenges in the Delivery of Mental Healthcare during COVID-19
por: Gautam, Mohan, et al.
Publicado: (2020)

Rising evidence for neurological involvement in COVID-19 pandemic
por: Calcagno, Narghes, et al.
Publicado: (2020)

Evidence of the importance of contact tracing in fighting COVID-19
por: Kwon, Okyu
Publicado: (2022)

A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms
por: Tang, Xuhuan, et al.
Publicado: (2021)

Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
por: Pham, Amelie, et al.
Publicado: (2021)

Disputes over the production and dissemination of misinformation in the time of COVID-19
por: Cazzola, Mario, et al.
Publicado: (2021)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

Happy hypoxemia, or blunted ventilation?
por: Ora, Josuel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ss0q5n4mu314ih9ulcqn0bmoei